ArticleMolecules (Basel, Switzerland)2026
Co-Occurrence of 5-Hydroxymethylfurfural and Patulin in Reconstituted Pomegranate Juice: Analytical Determination and Risk Assessment.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
5-Hydroxymethylfurfural (5-HMF) and the mycotoxin patulin (PAT) serve as crucial chemical markers for evaluating the quality and safety of fruit-derived beverages, particularly pomegranate juice. This study aimed to quantify the occurrence of 5-HMF and PAT in commercial reconstituted pomegranate juices and assess the associated dietary exposure risks. A total of 154 commercial samples, collected from a Turkish processing facility during the 2024-2025 production seasons, were analysed using high-performance liquid chromatography with diode-array detection. 5-HMF was detected in 152 samples (98.7%) at concentrations ranging from 1.03 to 10.79 mg/kg, with only two samples (1.3%) exceeding the critical threshold of 10 mg/kg. PAT was found in 57 samples (37.0%), with concentrations between 3.61 and 50.69 µg/kg, and only one sample (0.6%) exceeded the European Union maximum level established for fruit juices. Estimated mean daily intakes for adults and children ranged from 0.374 to 2.362 and 1.139 to 8.546 µg/kg bw/day for 5-HMF, and from 0.001 to 0.006 and 0.002 to 0.021 µg/kg bw/day for PAT, respectively. Risk characterisation based on hazard quotient values indicated that PAT exposure did not pose a significant health risk for either population group, highlighting the overall safety of the analysed products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.